Related Experiment Video
Updated: Jul 19, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[Hepatocellular carcinoma in Iceland.]
B Ragnarsdóttir1, J G Jónasson, H Tulinius
1Department of Medicine, Landspitali University Hospital, Fossvogi, 108 Reykjavík, Iceland. sigurdol@landspitali.is.
Laeknabladid
|October 5, 2006
Summary
Hepatocellular carcinoma (HCC) incidence in Iceland is low, with alcohol abuse and hemochromatosis as primary risk factors. Cirrhosis prevalence was notably low among HCC patients in this study.
Area of Science:
- Hepatology
- Oncology
- Epidemiology
Context:
- Hepatocellular carcinoma (HCC) incidence varies globally, with lower rates observed in Northern Europe.
- Iceland has a lower prevalence of viral hepatitis and cirrhosis, key HCC risk factors.
- Understanding HCC etiology in low-incidence regions is crucial for targeted prevention.
Purpose:
- To determine the incidence and etiological factors of hepatocellular carcinoma (HCC) in Iceland.
- To analyze HCC cases diagnosed between 1984 and 1998.
- To identify prevalent risk factors and patient characteristics in the Icelandic HCC population.
Summary:
- A total of 71 HCC cases were identified in Iceland from 1984-1998.
- The age-standardized annual incidence rate was 1.08 per 100,000 population.
- Alcohol abuse (15.5%) and hemochromatosis (11%) were the most frequent risk factors; 55% had no known risk factors and 32% had cirrhosis.
Impact:
- Establishes a benchmark for HCC incidence in Iceland.
- Highlights alcohol abuse and hemochromatosis as significant etiological factors in this population.
- Suggests a lower role of cirrhosis in HCC development in Iceland compared to other regions.
Related Concept Videos
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...